title: Highly attenuated vaccinia virus DIs as a potential SARS vaccine.
authors.affiliation: National Institute of Infectious Diseases, Tokyo, Japan.
authors.forename: Koji
authors.initials: K
authors.lastname: Ishii
authors.forename: Hideki
authors.initials: H
authors.lastname: Hasegawa
authors.forename: Noriyo
authors.initials: N
authors.lastname: Nagata
authors.forename: Tetsuya
authors.initials: T
authors.lastname: Mizutani
authors.forename: Shigeru
authors.initials: S
authors.lastname: Morikawa
authors.forename: Masato
authors.initials: M
authors.lastname: Tashiro
authors.forename: Tetsuro
authors.initials: T
authors.lastname: Suzuki
authors.forename: Fumihiro
authors.initials: F
authors.lastname: Taguchi
authors.forename: Toshitada
authors.initials: T
authors.lastname: Takemori
authors.forename: Tatsuo
authors.initials: T
authors.lastname: Miyamura
authors.forename: Yasuko
authors.initials: Y
authors.lastname: Tsunetsugu-Yokota
mesh_terms: D000818:Animals; D000914:Antibodies, Viral / Q000737:chemistry; D006801:Humans; D007074:Immunoglobulin G / Q000737:chemistry; D051379:Mice; D008807:Mice, Inbred BALB C; D011994:Recombinant Proteins / Q000737:chemistry; D045473:Severe acute respiratory syndrome-related coronavirus / Q000235:genetics*; D045169:Severe Acute Respiratory Syndrome / Q000235:genetics* / Q000517:prevention & control*; D014616:Vaccinia virus / Q000378:metabolism*; D014759:Viral Envelope Proteins; D014765:Viral Vaccines / Q000494:pharmacology*
chemical_list: D000914:Antibodies, Viral; D007074:Immunoglobulin G; D011994:Recombinant Proteins; D014759:Viral Envelope Proteins; D014765:Viral Vaccines